Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Gao, Dong, Vela, Ian, Sboner, Andrea, Iaquinta, Phillip J., Karthaus, Wouter R., Gopalan, Anuradha, Dowling, Catherine, Wanjala, Jackline N. +31 more·2014·Cell
DOI 10.1016/j.cell.2014.08.016

Cited by (1,000)

Items 701–800 of 1,000

  1. Integration of Organoids With CRISPR Screens: A Narrative Review
    Rushikesh Mukhare, Khushboo Gandhi, Anushree Kadam, Aishwarya Raja, Ankita Singh, Mrudula Madhav, Rohan Chaubal, Shwetali Pandey, Sudeep Gupta · 2025 · Biology of the Cell
  2. In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?
    Giovanna Cassone Salata, Camila Megumi Hirokawa, Giovanna Barros de Melo, Isabella D. Malagó, Jessica Ribeiro Nunes, Julia Sapienza Passos, Regina G. Daré, Luciana B. Lopes · 2025 · Cancer Nanotechnology
  3. Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives
    Floriana Jessica Di Paola, Giulia Calafato, Pier Paolo Piccaluga, Giovanni Tallini, Kerry Jane Rhoden · 2025 · Journal of Personalized Medicine
  4. Bioengineering Hematopoietic Stem Cell Niche toward Regenerative Medicine
    Ryohichi Sugimura · 2015 · Advanced Drug Delivery Reviews
  5. Functional/activity network (FAN) analysis of gene-phenotype connectivity liaised by grape polyphenol resveratrol
    Tze‐chen Hsieh, Sheng-Tang Wu, Dylan John Bennett, Barbara B. Doonan, Erxi Wu, JOSEPH M. WU · 2016 · Oncotarget
  6. Liquid Biopsy and Their Application Progress in Head and Neck Cancer: Focus on Biomarkers Ctcs, Cfdna, Ctdna and Evs
    Yiling Meng, Lei Bian, Meichao Zhang, Fang Bo, Xiao Lu, Dong Li · 2020 · Biomarkers in Medicine
  7. Systems Biology and Experimental Model Systems of Cancer
    Gizem Damla Yalçın, Nurseda Danisik, Rana Can Baygin, Ahmet Acar · 2020 · Journal of Personalized Medicine
  8. Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin
    Stefan Richard Bornstein, Igor Shapiro, Maria Malyukov, Richard Züllig, Edlira Luca, Evgeny Gelfgat, Felix Beuschlein, Svenja Nölting, Alfredo Berruti, Sandra Sigala et al. · 2022 · Cell Death and Disease
  9. Interplay of Developmental Hippo–Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer
    Ioanna Mourkioti, Andriani Angelopoulou, Konstantinos Belogiannis, Nefeli Lаgopati, Spyridon Potamianos, Efthymios Kyrodimos, Vassilis G. Gorgoulis, Angelos Papaspyropoulos · 2022 · Cells
  10. Genomic and Epigenomic Characterization of Tumor Organoid Models
    Chehyun Nam, Benjamin Ziman, Megha Sheth, Hua Zhao, De‐Chen Lin · 2022 · Cancers
  11. Circulating tumor cells and their role in prostate cancer
    Arnulf Stenzl, Moritz Maas, Miriam Hegemann, Steffen Rausch, Jens Bedke, Tilman Todenhöfer · 2019 · Asian Journal of Andrology
  12. Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro
    Claudia Paindelli, Nora Maria Navone, Christopher J. Logothetis, Peter Friedl, Eleonora Dondossola · 2019 · Biomaterials
  13. Dynamic in vitro models for tumor tissue engineering
    Daniel Karami, Nathan R. Richbourg, Vassilios I. Sikavitsas · 2019 · Cancer Letters
  14. Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises
    Chiara Argentati, Ilaria Tortorella, Martina Bazzucchi, Francesco Morena, Sabata Martino · 2020 · Journal of Personalized Medicine
  15. Preclinical Models of Neuroendocrine Neoplasia
    Andrew J. H. Sedlack, Kimia Saleh-Anaraki, Suresh Kumar, Po Hien Ear, Kate E Lines, Nitin Roper, Karel Pacák, Emily K. Bergsland, Dawn E. Quelle, James R. Howe et al. · 2022 · Cancers
  16. Fluidic Logic Used in a Systems Approach to Enable Integrated Single-Cell Functional Analysis
    Naveen Ramalingam, Brian Fowler, Lukasz Szpankowski, Anne A. Leyrat, Kyle W. Hukari, Myo Thu Maung, Wiganda Yorza, Michael Norris, Chris Cesar, Joe Shuga et al. · 2016 · Frontiers in Bioengineering and Biotechnology
  17. PDAC as an immune evasive disease: can 3D model systems aid to tackle this clinical problem?
    Narayanan, Shruthi, Vicent, Silve, Ponz-Sarvisé, Mariano · 2021 · Frontiers in Cell and Developmental Biology
  18. Organoid-based personalized medicine: from tumor outcome prediction to autologous transplantation
    Abel Soto-Gamez, Jeremy P Gunawan, Lara Barazzuol, Sarah A. Pringle, Robert Paul Coppes · 2024 · Stem Cells
  19. The biological macromolecules constructed Matrigel for cultured organoids in biomedical and tissue engineering
    Ke-yu Zhao, Yu Du, Huimin Cao, Liya Su, Xiulan Su, Xian Li · 2024 · Colloids and Surfaces B Biointerfaces
  20. Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
    Ninghui Mao, Young Sun Lee, Nazifa Salsabeel, Zeda Zhang, Dan Li, Harmanpreet Kaur, Xiaoping Chen, Qing Chang, Sanjoy Mehta, Jesse Barnes et al. · 2025 · Science Advances
  21. Clinical applications of circulating tumor cells in metastasis and therapy
    Chuan Yang, Can Liu, Chenglai Xia, Liwu Fu · 2025 · Journal of Hematology & Oncology
  22. Patient-derived xenografts: A platform for accelerating translational research in prostate cancer
    Alastair Davies, Yuzhuo Z. Wang, Amina Zoubeidi · 2017 · Molecular and Cellular Endocrinology
  23. Targeted AKT Inhibition in Prostate Cancer Cells and Spheroids Reduces Aerobic Glycolysis and Generation of Hyperpolarized [1-13C] Lactate
    Sui Seng Tee, Izabela Suster, Steven Truong, Sangmoo Jeong, Roozbeh Eskandari, Valentina DiGialleonardo, Julio A. Alvarez, Hannah N. Aldeborgh, Kayvan R. Keshari · 2018 · Molecular Cancer Research
  24. Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2 -altered Prostate Tumors
    Goutam Chakraborty, Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Zhang Mazzu, Yuki Yoshikawa, Mohammad Omar Atiq, Lina E. Jehane, Konrad Hermann Stopsack, Gwo‐Shu Mary Lee et al. · 2020 · Clinical Cancer Research
  25. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform
    Bo Pan, Dongyi Zhao, Yaqian Liu, Na Li, Chen Song, Ning Li, Xuelu Li, Zuowei Zhao · 2021 · In Vitro Cellular & Developmental Biology - Animal
  26. Optimization of tumor spheroid model in mesothelioma and lung cancers and anti-cancer drug testing in H2052/484 spheroids
    Dylan AJ Gendre, Edis Ameti, Wolfram Karenovicŝ, Nadja Perriraz, Frédéric Triponez, Véronique Serre‐Beinier · 2021 · Oncotarget
  27. Human liver organoids for disease modeling of fibrolamellar carcinoma
    Nicole J.C. Narayan, David Requena, Gadi Lalazar, Lavoisier S. Ramos-Espiritu, Denise Ng, Solomon Levin, Bassem Shebl, Ruisi Wang, William J. Hammond, James A. Saltsman et al. · 2022 · Stem Cell Reports
  28. Use and application of organ-on-a-chip platforms in cancer research
    Yifan Yu, Tingting Zhou, L.-L. Cao · 2023 · Journal of Cell Communication and Signaling
  29. Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo
    Takeshi Sasaki, Omar E. Franco, Simon W. Hayward · 2017 · Differentiation
  30. Cancer stem cells in breast and prostate: Fact or fiction?
    Rocío G. Sampayo, Mina J. Bissell · 2019 · Advances in cancer research
  31. A Novel Human Colon Signet-Ring Cell Carcinoma Organoid Line: Establishment, Characterization and Application
    Yaqi Li, Renjie Wang, Dan Huang, Xiaoji Ma, Shaobo Mo, Qiang Guo, Guoxiang Fu, Yuanchuang Li, Xiaoya Xu, Xiang Hu et al. · 2019 · Carcinogenesis
  32. Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids
    Francesco Amato, Colin J. Rae, Maria Giuseppina Prete, Chiara Braconi · 2020 · Cells
  33. Tumor mutational landscape is a record of the pre-malignant state
    Kirsten Kübler, Rosa Karlić, Nicholas J. Haradhvala, Kyungsik Ha, Jaegil Kim, Maja Kuzman, Wei Jiao, Sitanshu Gakkhar, Kent William Mouw, Lior Zvi Braunstein et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Feasibility analysis of using patient-derived tumour organoids for treatment decision guidance in locally advanced head and neck squamous cell carcinoma
    Anne-Sophie Fisch, Ana Pestana, Vanessa Sachse, Christian Doll, Elena Hofmann, Max Heiland, Theresa Obermueller, Jan Heidemann, Steffen Dommerich, Diana Schoppe et al. · 2024 · European Journal of Cancer
  35. Single-cell RNA sequencing and machine learning provide candidate drugs against drug-tolerant persister cells in colorectal cancer
    Yosui Nojima, Ryoji Yao, Takashi Suzuki · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  36. A New Perspective on Precision Medicine: The Power of Digital Organoids
    Qian Yang, Mengmeng Li, Zian Xiao, Yekai Feng, Lanjie Lei, Shisheng Li · 2025 · Biomaterials Research
  37. Spatially resolved transcriptomic analysis of the adult human prostate
    Junyi Hu, Fei Liu, Jing Zhang, Lei Yin, Wanli Cao, Weidong Xu, Yifan Chang, Ye Wang, Jian Wang, Yaxin Hou et al. · 2025 · Nature Genetics
  38. Human Organoids and Their Application in Tumor Models, Disease Modeling, and Tissue Engineering
    Siyuan Song, Zheng Liu, Yi Wang, Bo Gong · 2025 · Medicine Bulletin
  39. Single-cell analysis uncovers preserved prostate cancer lineages and universally altered pathways in Matrigel-free patient-derived organoids
    Robin Dolgos, Romuald Parmentier, Jing Wang, Raphaëlle Servant, Arnoud J. Templeton, Tobias Zellweger, Alastair D. Lamb, Kirsten D. Mertz, Svetozar Subotic, Tatjana Vlajnic et al. · 2025 · Cell Reports
  40. DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer
    Wennuan Liu · 2016 · Asian Journal of Andrology
  41. Tumor cell heterogeneity and resistance; report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting
    Andrea K. Miyahira, Robert Benjamin Den, Maria Isabel Carlo, Renée de Leeuw, Thomas A. Hope, Fatima H. Karzai, Rana R. McKay, Simpa Samuel Salami, Jonathan W. Simons, Kenneth J. Pienta et al. · 2018 · The Prostate
  42. Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids
    Sanghee Lee, Theresa R. Mendoza, Danielle N. Burner, Michelle T. Muldong, Christina C. N. Wu, Catalina Arreola, Abril Zuniga, Olga Greenburg, William Y. Zhu, Jamillah Murtadha et al. · 2022 · International Journal of Molecular Sciences
  43. Patient-Derived Organoids of Colorectal Cancer: A Useful Tool for Personalized Medicine
    Takumi Kiwaki, Hiroaki Kataoka · 2022 · Journal of Personalized Medicine
  44. Modeling prostate cancer: What does it take to build an ideal tumor model?
    Chun‐Wai Mai, Kok‐Yong Chin, Lian Chee Foong, Kok-Lun Pang, Bin Yu, Yu Shu, Sisi Chen, Soon‐Keng Cheong, Chee Wai Chua · 2022 · Cancer Letters
  45. Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment
    Shu Ning, Chengfei Liu, Wei Lou, Joy C. Yang, Alan Paul Lombard, Leandro Salati D'Abronzo, Neelu Batra, Ai‐Ming Yu, Amy Rose Leslie, Masuda Sharifi et al. · 2022 · Molecular Cancer Therapeutics
  46. Will Organoids Fill the Gap towards Functional Precision Medicine?
    Federica Papaccio, Manuel Cabeza-Segura, Blanca García-Micó, Noelia Tarazona, Desamparados Roda, Josefa Castillo, Andrès M.R. Cervantes · 2022 · Journal of Personalized Medicine
  47. Organoids of the male reproductive system: Challenges, opportunities, and their potential use in fertility research
    Daniela Patrício, Joana Santiago, João Filipe Mano, Margarida Fardilha · 2022 · WIREs Mechanisms of Disease
  48. PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition
    Joanna Triscott, Matthias Reist, L KUNG, Francielle Caroline Mosele, Marika Lehner, John Gallon, Archna Ravi, Gurpreet K. Arora, Simone de Brot, Mark R. Lundquist et al. · 2023 · Science Advances
  49. Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
    Evangelia Sereti, Irida Papapostolou, KONSTANTINOS S. DIMAS · 2023 · Biomedicines
  50. Bioprinted research models of urological malignancy
    Guanyi Wang, Xiongmin Mao, Wang Wang, Wang Xiaolong, Sheng Li, Zijian Wang · 2024 · Exploration
  51. Organoids reveal cancer dynamics
    Calvin Jay Kuo, Christina N. Curtis · 2018 · Nature
  52. An overview of publicly available patient-centered prostate cancer datasets
    Tim Hulsen · 2019 · Translational Andrology and Urology
  53. Brain Organoids: A Promising Living Biobank Resource for Neuroscience Research
    Shuang Li, Min Wang, Junmei Zhou · 2020 · Biopreservation and Biobanking
  54. Prostate Cancer Spheroids: A Three-Dimensional Model for Studying Tumor Heterogeneity
    Mauricio Rodríguez‐Dorantes, Carlos D. Cruz-Hernández, Sergio Alberto Cortés-Ramírez, Marian Cruz-Burgos, Juan Pablo Reyes‐Grajeda, Óscar Peralta-Zaragoza, Alberto Losada-García · 2020 · Methods in molecular biology
  55. Modeling cancer progression using human pluripotent stem cell-derived cells and organoids
    Meili Zhang, J. Jeya Vandana, Lauretta A. Lacko, Shuibing Chen · 2020 · Stem Cell Research
  56. Predictive Value of EGFR-PI3K-AKT-mTOR-Pathway Inhibitor Biomarkers for Head and Neck Squamous Cell Carcinoma: A Systematic Review
    Willem W. B. de Kort, Sacha Spelier, Lot A. Devriese, Robert J.J. van Es, Stefan M. Willems · 2021 · Molecular Diagnosis & Therapy
  57. Construction of cancer-on-a-chip for drug screening
    Yan Liu, Qingzhen Yang, Hui Zhang, Shuang Han, Na Liu, Hui Jun Ren, Hui Guo, Feng Xu · 2021 · Drug Discovery Today
  58. Personalizing Therapy for Metastatic Prostate Cancer: The Role of Solid and Liquid Tumor Biopsies
    Terence W. Friedlander, Colin C. Pritchard, Himisha Beltran · 2017 · American Society of Clinical Oncology Educational Book
  59. Isolation and analysis of discreet human prostate cellular populations
    Douglas W. Strand, LaTayia Aaron, Gervaise H. Henry, Omar E. Franco, Simon W. Hayward · 2015 · Differentiation
  60. From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity
    Guido Gambara, Manuela Gaebler, Ulrich Keilholz, Christian R. A. Regenbrecht, Alessandra Silvestri · 2018 · Frontiers in Pharmacology
  61. Modelling the tumor microenvironment in vitro in prostate cancer: current and future perspectives
    Kedi Yuan, Xinxing Du, Liang Dong, Jiahua Pan, Wei Xue · 2024 · Open Research (University of Surrey)
  62. AGD1/USP10/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer
    Hong Wang, Chunli Cui, Weiyi Li, Hui Wu, Jianjun Sha, Jiahua Pan, Wei Xue · 2025 · Journal of Experimental & Clinical Cancer Research
  63. Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A–menin to bivalent promoters
    Naitao Wang, Mohini R. Pachai, Dan Li, Cindy J. Lee, Sarah Warda, Makhzuna N. Khudoynazarova, Woo Hyun Cho, Guojia Xie, Sagar R Shah, Yao Li et al. · 2025 · Nature Genetics
  64. Organoids technology in cancer research: from basic applications to advanced ex vivo models
    Luca Varinelli, Oscar Illescas, Ewelina Lorenc, Davide Battistessa, Marzia Di Bella, Susanna Zanutto, Manuela Gariboldi · 2025 · Frontiers in Cell and Developmental Biology
  65. RETRACTED ARTICLE: NSD2 targeting reverses plasticity and drug resistance in prostate cancer
    Jia J. Li, Alessandro Vasciaveo, Dimitris Karagiannis, Zhen Sun, Kristjan H. Gretarsson, Xiao Chen, Ouathek Ouerfelli, Fabio Socciarelli, Ziv Frankenstein, Hanyang Dong et al. · 2025 · Nature · Retracted
  66. TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN -loss
    Karolina Pietrzak, Rostyslav Kuzyakiv, Ronald Simon, Marco Bolis, Dominik Bär, Rossana Aprigliano, Jean-Philippe Paul. Theurillat, Guido Sauter, Raffaella Santoro · 2020 · Proceedings of the National Academy of Sciences
  67. Novel organoid model in drug screening: Past, present, and future
    Xialin Nie, Zhixing Liang, Kun Li, Haoyuan Yu, Yu‐Han Huang, Linsen Ye, Yang� Yang · 2021 · Liver Research
  68. Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models
    Arjanneke F. van de Merbel, Geertje van der Horst, Maaike H. van der Mark, Selas T. F. Bots, Diana J.M. van den Wollenberg, Corrina M. A. de Ridder, Debra C. Stuurman, Tilly Wilhelmina Aalders, Sigrun Erkens‐Schulze, Nadine van Montfoort et al. · 2021 · Cancer Gene Therapy
  69. Liquid Biopsy, the hype vs. hope in molecular and clinical oncology
    Abhishek Mohanty, Sambit Kumar Mohanty, Sipra Rout, C Pani · 2021 · Seminars in Oncology
  70. Ex vivo expansion of circulating tumour cells (CTCs)
    Bashir M. Mohamed, Mark P. Ward, Mark Bates, Cathy D. Spillane, Tanya E. Kelly, Cara M. Martin, Michael F. Gallagher, Sheena Heffernan, Lucy Norris, John Kennedy et al. · 2023 · Scientific Reports
  71. Strong Elastic Protein Nanosheets Enable the Culture and Differentiation of Induced Pluripotent Stem Cells on Microdroplets
    Elijah Mojares, Clémence Nadal, Daniel Hayler, Hassan Kanso, Alexandra Chrysanthou, Carlos Eduardo Neri-Cruz, Julien E. Gautrot · 2024 · Advanced Materials
  72. Adaptive Multifunctional Supramolecular Assemblies of Glycopeptides Rapidly Enable Morphogenesis
    Jie Zhou, Xuewen Du, Xiaoyi Chen, Bing Xu · 2018 · Biochemistry
  73. The Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer Care
    John G. Clohessy, Pier Paolo Pandolfi · 2018 · Frontiers in Oncology
  74. Engineering Prostate Cancer from Induced Pluripotent Stem Cells—New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies
    Anastasia C. Hepburn, Clive Sims, Adriana Buskin, Rakesh Heer · 2020 · International Journal of Molecular Sciences
  75. Design and Fabrication of Three-Dimensional Printed Scaffolds for Cancer Precision Medicine
    Abbas Shafiee · 2020 · Tissue Engineering Part A
  76. Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling
    Erika Héninger, David Kosoff, Tamara S. Rodems, Nan Sethakorn, Anupama Singh, Harshitha Gungurthi, Kristin N. Carlson, Bing Yang, Cole S. Gilsdorf, Cheri A. Pasch et al. · 2021 · Medical Oncology
  77. Isolation of label-free and viable circulating tumour cells (CTCs) from blood samples of cancer patients through a two-step process: negative selection-type immunomagnetic beads and spheroid cell culture-based cell isolation
    Liao, Chia-Jung, Hsieh, Chia-Hsun, Wang, Hung-Ming, Chou, Wen-Pin, Chiu, Tzu-Keng, Chang, Jyun-Huan, Chao, A.-Ching, Wu, Min-Hsien · 2017 · RSC Advances
  78. Organoids: Principle, application and perspective
    Kaizheng Liu, Xinyi Fang, Abdellah Aazmi, Qingzhe Wang, Xiaofeng Gong, Zhengkun Chen, Minghao Qin, Chunyi Pu, Ying Zhao, Xiaozhong Qiu et al. · 2024 · The Innovation Life
  79. Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer
    Shankha Subhra Chatterjee, Juan F. Linares, Tania Cid-Diaz, Ángeles Durán, Mohd. Imran K. Khan, Marta Osrodek, Nicholas J. Brady, Miguel Reina‐Campos, Antonio Marzio, Varadha Balaji Venkadakrishnan et al. · 2024 · Nature Communications
  80. Perspective of 3D culture in medicine: transforming disease research and therapeutic applications
    Chan Hum Park, Jung Ho Park, Yong Joon Suh · 2024 · Frontiers in Bioengineering and Biotechnology
  81. Epidermal Growth Factor Is Essential for the Maintenance of Novel Prostate Epithelial Cells Isolated From Patient-Derived Organoids
    Katia Anis Cheaito, Hisham F. Bahmad, Hiba A. Jalloul, Ola Hadadeh, Hiba Msheik, Albert El Hajj, Deborah Mukherji, Mohamed Al‐Sayegh, Wassim G. Abou-Kheir · 2020 · Frontiers in Cell and Developmental Biology
  82. Brain organoids: Establishment and application
    Hao Chen, Xin Jin, Tie Li, Zhuang Ye · 2022 · Frontiers in Cell and Developmental Biology
  83. Isolation, Detection and Analysis of Circulating Tumour Cells: A Nanotechnological Bioscope
    Upama Das, Soumyabrata Banik, Sharmila Sajankila Nadumane, Shweta Chakrabarti, Dharshini Gopal, Shama Prasada Kabekkodu, Pornsak Srisungsitthisunti, Nirmal Mazumder, Rajib Biswas · 2023 · Pharmaceutics
  84. A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids
    Ruixin Yang, Yutong Du, Wingyan Kwan, Ranlin Yan, Qimeng Shi, Lu Zang, Zhenggang Zhu, Jianming Zhang, Chen Li, Yingyan Yu · 2023 · Cancer Biology and Medicine
  85. UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance
    Carla R. Tirado, Choushi Wang, Xiaoling Li, Su Deng, Julisa Gonzalez, Nickolas A. Johnson, Yaru Xu, Lauren A. Metang, Medha Sundar Rajan, Yuqiu Yang et al. · 2023 · Oncogene
  86. Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research
    Mohammad Waseem, Bi‐Dar Wang · 2024 · International Journal of Molecular Sciences
  87. From biology to the clinic — exploring liver metastasis in prostate cancer
    Xudong Ni, Wei Yu, Xiaomeng Li, Jian Pan, Bangwei Fang, Tingwei Zhang, Ying Lu, Dingwei Ye, Yao Zhu · 2024 · Nature Reviews Urology
  88. A Decade of Organoid Research: Progress and Challenges in the Field of Organoid Technology
    Basheer Ahammed, Suresh Kumar Kalangi · 2024 · ACS Omega
  89. The culture and application of circulating tumor cell-derived organoids
    Can Pan, Xueping Wang, Chuan Yang, Kai Fu, Fang Wang, Liwu Fu · 2024 · Trends in Cell Biology
  90. Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells
    Lucas Tricoli, Aisha Naeem, Erika Parasido, John Paul Mikhaiel, Muhammad Umer Choudhry, Deborah L. Berry, Iman Attia Abdelgawad, Richard J. Lee, Adam Scott Feldman, Chukwuemeka U. Ihemelandu et al. · 2017 · Oncotarget
  91. Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
    Kyrie Pappas, Danielle Choi, Charles L. Sawyers, Wouter R. Karthaus · 2019 · Journal of Visualized Experiments
  92. Changes in autofluorescence based organoid model of muscle invasive urinary bladder cancer
    Scott G. Palmer, Karina S. Litvinova, Andrey Dunaev, Stewart Fleming, David McGloin, Ghulam Nabi · 2016 · Biomedical Optics Express
  93. The Genomics of Prostate Cancer: A Historic Perspective
    Mark A. Rubin, Francesca Demichelis · 2018 · Cold Spring Harbor Perspectives in Medicine
  94. In vitro co-culture models for studying organoids-macrophages interaction: the golden technology of cancer immunotherapy
    Jinming Liu · 2024 · American Journal of Cancer Research
  95. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes
    Ninghui Mao, Dong Gao, Wenhuo Hu, Haley Hieronymus, Shangqian Wang, Young Sun Lee, Cindy Lee, Danielle Choi, Anuradha Gopalan, Yu Chen et al. · 2019 · Molecular Cancer Therapeutics
  96. Copper promotes sheep pancreatic duct organoid growth by activation of an antioxidant protein 1-dependent MEK-ERK pathway
    Miao Liu, Wen Liang Yu, Jing Jin, Mingjun Ma, AN Tie-zhu, Yuzhe Nie, Chun‐Bo Teng · 2020 · American Journal of Physiology-Cell Physiology
  97. MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?
    Thomas Andl, Kavya Ganapathy, Alexia Bossan, Ratna Chakrabarti · 2020 · International Journal of Molecular Sciences
  98. Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes
    Korie A. Grayson, Nidhi Jyotsana, Nerymar Ortiz-Otero, Michael R. King · 2021 · PLoS ONE
  99. Functional genomics approaches to improve pre‐clinical drug screening and biomarker discovery
    Long V Nguyen, Carlos Caldas · 2021 · EMBO Molecular Medicine
  100. Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response
    Geny Piro, Antonio Agostini, Alberto Larghi, Giuseppe Quero, Carmine Carbone, Annachiara Esposito, Gianenrico Rizzatti, Fabia Attili, Sergio Alfieri, Guido Costamagna et al. · 2021 · Frontiers in Medicine